RIVERNORTH CAPITAL MANAGEMENT, LLC - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 46 filers reported holding PHOENIX BIOTECH ACQUISITION in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RIVERNORTH CAPITAL MANAGEMENT, LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2022$505,000
+0.8%
49,9960.0%0.02%
+15.0%
Q2 2022$501,000
+0.2%
49,9960.0%0.02%
+5.3%
Q1 2022$500,000
+0.8%
49,9960.0%0.02%
-5.0%
Q4 2021$496,00049,9960.02%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q1 2022
NameSharesValueWeighting ↓
Beryl Capital Management LLC 1,230,264$12,192,0000.63%
CANTOR FITZGERALD, L. P. 750,000$7,433,0000.53%
Atalaya Capital Management LP 450,000$4,460,0000.44%
Telemetry Investments, L.L.C. 30,634$304,0000.39%
NEXPOINT ASSET MANAGEMENT, L.P. 217,482$2,155,0000.30%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,037,794$10,285,0000.22%
BERKLEY W R CORP 296,730$2,941,0000.16%
MMCAP International Inc. SPC 250,000$2,478,0000.15%
CVI Holdings, LLC 195,500$1,937,0000.13%
CSS LLC/IL 318,210$3,153,0000.11%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders